Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'20
Mar'19
Mar'18
Mar'17
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is -85.71% vs NA in Mar 2024
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is 0.00% vs NA in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is -42.86% vs NA in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 0.00% vs NA in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is 25,550.00% vs NA in Mar 2024
Compare Balance Sheet Results of Venmax Drugs
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
5.24
4.45
0.79
17.75%
Share Warrants & Outstandings
Total Reserve
-5.90
-6.44
0.54
8.39%
Shareholder's Funds
4.41
-1.99
6.40
321.61%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
8.09
-8.09
-100.00%
Secured Loans
0.00
5.10
-5.10
-100.00%
Unsecured Loans
0.00
2.99
-2.99
-100.00%
Deferred Tax Assets / Liabilities
0.00
-0.19
0.19
100.00%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
0.00
7.51
-7.51
-100.00%
Current Liabilities
Trade Payables
0.63
10.22
-9.59
-93.84%
Other Current Liabilities
0.08
2.24
-2.16
-96.43%
Short Term Borrowings
0.05
0.00
0.05
0.00%
Short Term Provisions
0.00
0.59
-0.59
-100.00%
Total Current Liabilities
0.76
13.04
-12.28
-94.17%
Total Liabilities
5.17
18.56
-13.39
-72.14%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
0.04
17.69
-17.65
-99.77%
Less: Accumulated Depreciation
0.00
9.72
-9.72
-100.00%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
0.04
7.97
-7.93
-99.50%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
0.40
-0.40
-100.00%
Long Term Loans & Advances
0.00
0.18
-0.18
-100.00%
Other Non Current Assets
0.00
0.00
0.00
0.00%
Total Non-Current Assets
0.04
8.56
-8.52
-99.53%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
0.06
3.31
-3.25
-98.19%
Sundry Debtors
0.95
1.28
-0.33
-25.78%
Cash and Bank
2.48
0.09
2.39
2,655.56%
Other Current Assets
0.03
0.00
0.03
0.00%
Short Term Loans and Advances
1.61
5.32
-3.71
-69.74%
Total Current Assets
5.13
10.00
-4.87
-48.70%
Net Current Assets (Including Current Investments)
4.37
-3.03
7.40
244.22%
Total Current Assets Excluding Current Investments
5.13
10.00
-4.87
-48.70%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
5.17
18.56
-13.39
-72.14%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
0.05
7.32
-7.27
-99.32%
Book Value per share (adjusted)
-1.26
-4.47
3.21
71.81%
Annual - Borrowings
Borrowings 0.05 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -85.71% vs NA in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
YoY Growth in year ended Mar 2025 is 0.00% vs NA in Mar 2024
Annual - Fixed Assets
Fixed Assets 0.04 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -42.86% vs NA in Mar 2024
Annual - Investments
No Investments in the last few periods
YoY Growth in year ended Mar 2025 is 0.00% vs NA in Mar 2024
Annual - Current Assets
Current Assets 5.13 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 25,550.00% vs NA in Mar 2024
